- Home
- GRC vs SANA Comparison
GRC vs SANA Comparison
Compare GRC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRC | SANA |
|---|---|---|
| Founded | 1933 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GRC | SANA |
|---|---|---|
| Price | $77.41 | $3.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $7.80 |
| AVG Volume (30 Days) | 146.8K | ★ 3.1M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 32.03 | 17.24 |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $682,389,000.00 | N/A |
| Revenue This Year | $6.62 | N/A |
| Revenue Next Year | $4.66 | N/A |
| P/E Ratio | $112.66 | ★ N/A |
| Revenue Growth | ★ 3.44 | N/A |
| 52 Week Low | $34.96 | $1.98 |
| 52 Week High | $79.54 | $6.55 |
Technical Indicators
Market Signals| Indicator | GRC | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 64.50 | 53.17 |
| Support Level | $42.77 | $2.88 |
| Resistance Level | $78.50 | $3.78 |
| Average True Range (ATR) | 3.17 | 0.22 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 87.59 | 49.72 |
Price Performance
Historical ComparisonAbout GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.